{"title":"Identification of Ferroptosis-Related Genes in Acute Ischemic Stroke Based on Bioinformatics Analysis and Prediction of Potential Therapeutic Drugs","authors":"Yunze Li, Yangjing Yao, Yan Liu, Qinghua Feng, Yuan Chen, Ying-Yu Lai, Jianjun Li, Minghua Wu","doi":"10.37290/ctnr2641-452x.21:306-314","DOIUrl":null,"url":null,"abstract":"Ferroptosis is a regulated cell death implicated in various diseases, including stroke. We have explored the ferroptosis related key genes and the underlying association with acute ischemic stroke. Differentially expressed mRNAs and miRNAs in ischemic stroke were screened based on the GSE16561 and GSE95204 datasets, respectively. Ferroptosis-related genes were downloaded from the FerrDb and GeneCards databases. Eleven ferroptosis-related differentially expressed genes were identified. Based on weighted gene co-expression network analysis, three key modules were identified as being closely associated with stroke. Furthermore, two hub genes, lysosomal associated membrane protein 2 and signal transducer and activator of transcription 3, were selected by a support vector machine-based recursive feature elimination algorithm based on machine learning and showed excellent diagnostic accuracy in stroke, with an area under the curve value of 0.939 and 0.875 in the GSE16561 cohort, respectively. Furthermore, the Comparative Toxicogenomic Database predicted 24 potential therapeutic drugs targeting the two hub genes. To sum up, the identification of hub genes associated with ferroptosis and acute ischemic stroke based on bioinformatics analysis may contribute to the exploration of promising diagnostic and therapeutic biomarkers and provide clues for the prediction of therapeutic candidates.","PeriodicalId":10976,"journal":{"name":"Current Topics in Nutraceutical Research","volume":" ","pages":""},"PeriodicalIF":0.4000,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Topics in Nutraceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.37290/ctnr2641-452x.21:306-314","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Ferroptosis is a regulated cell death implicated in various diseases, including stroke. We have explored the ferroptosis related key genes and the underlying association with acute ischemic stroke. Differentially expressed mRNAs and miRNAs in ischemic stroke were screened based on the GSE16561 and GSE95204 datasets, respectively. Ferroptosis-related genes were downloaded from the FerrDb and GeneCards databases. Eleven ferroptosis-related differentially expressed genes were identified. Based on weighted gene co-expression network analysis, three key modules were identified as being closely associated with stroke. Furthermore, two hub genes, lysosomal associated membrane protein 2 and signal transducer and activator of transcription 3, were selected by a support vector machine-based recursive feature elimination algorithm based on machine learning and showed excellent diagnostic accuracy in stroke, with an area under the curve value of 0.939 and 0.875 in the GSE16561 cohort, respectively. Furthermore, the Comparative Toxicogenomic Database predicted 24 potential therapeutic drugs targeting the two hub genes. To sum up, the identification of hub genes associated with ferroptosis and acute ischemic stroke based on bioinformatics analysis may contribute to the exploration of promising diagnostic and therapeutic biomarkers and provide clues for the prediction of therapeutic candidates.
期刊介绍:
Current Topics in Nutraceutical Research is an international, interdisciplinary broad-based peer reviewed scientific journal for critical evaluation of research on chemistry, biology and therapeutic applications of nutraceuticals and functional foods. The major goal of this journal is to provide peer reviewed unbiased scientific data to the decision makers in the nutraceutical and food industry to help make informed choices about development of new products.
To this end, the journal will publish two types of review articles. First, a review of preclinical research data coming largely from animal, cell culture and other experimental models. Such data will provide basis for future product development and/or human research initiatives. Second, a critical evaluation of current human experimental data to help market and deliver the product for medically proven use. This journal will also serve as a forum for nutritionists, internists, neurologists, psychiatrists, and all those interested in preventive medicine.
The common denominator of all of the topic to be covered by the journal must include nutraceuticals and/functional food. The following is an example of some specific areas that may be of interest to the journal. i) Role of vitamins, minerals, antioxidants and phytonutrients on cardiovascular health, cancer, diabetes, ocular health, mental health, men’s health, women’s health, infant nutrition, ii) Role of herbals on human health, iii) Dietary supplements and sleep, iv) Components of diet that may have beneficial effect on human health, v) regulation of apoptosis and cell viability, vi) Isolation and characterization of bioactive components from functional foods, vii) Nutritional genomics, and viii) Nutritional proteomics.